Evaluation of efficacy and safety of Lactobacillus rhamnosus in children aged 4–48 months with atopic dermatitis: An 8-week, double-blind, randomized, placebo-controlled study

Journal of Microbiology, Immunology and Infection

Volumn 50, Issue 5, 2017, Pages 684-692

  Wu, Yi Jie ^a   Wu, Wei Fong ^b,c   Hung, Chia Wei ^b   Ku, Ming Shiu ^a,d   Liao, Pei Fen ^a   Sun, Hai Lun ^a,d   Lu, Ko Hsiu ^d   Sheu, Ji Nan ^a,d   Lue, Ko Huang ^a,d  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c Siyuan Hospital   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

atopic dermatitis; efficacy; Lactobacillus rhamnosus

Indexed keywords

COMPROBI CAPSULE; CORTICOSTEROID; PLACEBO; PROBIOTIC AGENT;

ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL OUTCOME; CLINICAL PROTOCOL; CONTROLLED STUDY; DERMATITIS FAMILY IMPACT QUESTIONNAIRE; DERMATITIS QUALITY OF LIFE QUESTIONNAIRE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GROUPS BY AGE; HUMAN; INFANT; INTENTION TO TREAT ANALYSIS; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PRESCHOOL CHILD; QUALITY OF LIFE ASSESSMENT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING OF ATOPIC DERMATITIS; SCORING SYSTEM; SYMPTOM; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; PARENT; PHYSIOLOGY; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TAIWAN; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; LACTOBACILLUS RHAMNOSUS; MALE; PARENTS; PLACEBOS; PROBIOTICS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TAIWAN; TREATMENT OUTCOME;

EID: 84951727626     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2015.10.003     Document Type: Article

References (40)

1. Boguniewicz, M., Leung, D.Y.M., Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 242 (2011), 233–246.
2. Williams, H., Stewart, A., von Mutius, E., Cookson, W., Anderson, H.R., Is eczema really on the increase worldwide?. J Allergy Clin Immunol 121 (2008), 947–954.
3. Kapoor, R., Menon, C., Hoffstad, O., Bilker, W., Leclerc, P., Margolis, D.J., The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. J Am Acad Dermatol 58 (2008), 68–73.
4. DaVeiga, S.P., Epidemiology of atopic dermatitis: a review. Allergy Asthma Proc 33 (2012), 227–234.
5. Wu, W.F., Wan, K.S., Wang, S.J., Yang, W., Liu, W.L., Prevalence, severity, and time trends of allergic condition in 6-to-7 year old schoolchildren in Taipei. J Investig Allergol Clin Immunol 21 (2011), 556–562.
6. Eichenfield, L.F., Tom, W.L., Berger, T.G., Krol, A., Paller, A.S., Schwarzenberger, K., et al. Guidelines of care for the management of atopic dermatitis. J Am Acad Dermatol 71 (2014), 116–132.
7. Leung, D.Y.M., Boguniewicz, M., Howell, M.D., Nomura, I., Hamid, Q.A., New insights into atopic dermatitis. J Clin Invest 113 (2004), 651–657.
8. Krakowski, A.C., Eichenfield, L.F., Dohil, M.A., Management of atopic dermatitis in the pediatric population. Pediatrics 122 (2008), 812–824.
9. Winkler, P., Ghadimi, D., Schrezenmeir, J., Kraehenbuhl, J.P., Molecular and cellular basis of microflora–host interactions. J Nutr 137 (2007), S756–S772.
10. Isolauri, E., Sutas, Y., Kankaanpaa, P., Arvilommi, H., Salminen, S., Probiotics: effects on immunity. Am J Clin Nutr 73 (2001), S444–S450.
11. Heller, F., Duchmann, R., Intestinal flora and mucosal immune responses. Int J Med Microbiol 293 (2003), 77–86.
12. Sudo, N., Sawamura, S., Tanaka, K., Aiba, Y., Kubo, C., Koga, Y., The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 159 (1997), 1739–1745.
13. Orihara, K., Narita, M., Tobe, T., Akasawa, A., Ohya, Y., Matsumoto, K., et al. Circulating Foxp31CD41 cell numbers in atopic patients and healthy control subjects. J Allergy Clin Immunol 120 (2007), 960–962.
14. Ito, Y., Adachi, Y., Makino, T., Higashiyama, H., Fuchizawa, T., Shimizu, T., et al. Expansion of FOXP3-positive CD41CD251 T cells associated with disease activity in atopic dermatitis. Ann Allergy Asthma Immunol 103 (2009), 160–165.
15. Kwon, H.K., Lee, C.G., So, J.S., Chae, C.S., Hwang, J.S., Sahoo, A., et al. Generation of regulatory dendritic cells and CD41Foxp31 T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A 107 (2010), 2159–2164.
16. Fuller, R., Probiotics in human medicine. Gut 32 (1991), 439–442.
17. Majamaa, H., Isolauri, E., Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 99 (1997), 179–185.
18. Mack, D.R., Ahrne, S., Hyde, L., Wei, S., Hollingworth, A.M., Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52 (2003), 827–833.
19. Malin, M., Suomalinen, H., Saxelin, M., Isolauri, E., Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab 40 (1996), 137–145.
20. Perdigon, G., Alaqvarez, S., Nader de Marcias, M., Roux, M.E., de Ruiz Holgado, A.P., The oral administration of lactic acid bacteria increases the mucosal intestinal immunity in response to enteropathogens. J Food Protect 53 (1990), 404–410.
21. Moreau, M.C., Intestinal flora, probiotics and effects on the intestinal IgA immune response. Arch Pediatr 7 (2000), S247–S248.
22. Famularo, G., Moretti, S., Marcellini, S., de Simone, C., Probiotics and the immune system. Fuller, R., (eds.) Probiotics 2: Applications and practical aspects, 1997, Springer Netherlands, The Netherlands, 133–161.
23. Pessi, T., Sütas, U., Hurme, M., Isolauri, E., Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 30 (2000), 1804–1808.
24. Penders, J., Stobberingh, E.E., van den Brandt, P.A., Thijs, C., The role of the intestinal microbiota in the development of atopic disorders. Allergy 62 (2007), 1223–1236.
25. Betsi, G.I., Papadavid, E., Falagas, M.E., Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials. Am J Clin Invest 113 (2004), 651–657.
26. Rosenfeldt, V., Benfeldt, E., Nielsen, S.D., Michaelsen, K.F., Jeppesen, D.L., Valerius, N.H., et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 111 (2003), 389–395.
27. Gerasimov, S.V., Vasjuta, V.V., Myhovych, O.O., Bondarchuk, L.I., Probiotic supplement reduces atopic dermatitis in preschool children. A randomized, double-blind, placebo-controlled, clinical trial. Am J Clin Dermatol 11 (2010), 351–361.
28. Yeşilova, Y., Çalka, O., Akdeniz, N., Berktaş M., Effect of probiotics on the treatment of children with atopic dermatitis. Ann Dermatol 24 (2012), 189–193.
29. Weston, S., Halbert, A., Richmond, P., Prescott, S.L., Effects of probiotics on atopic dermatitis: a randomized controlled trial. Arch Dis Child 90 (2005), 892–897.
30. Van Der Aa, L.B., Heymans, H.S., Van Aalderen, W.M., Sillevis Smitt, J.H., Knol, J., Ben Amor, K., et al. Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial. Clin Exp Allergy 40 (2010), 795–804.
31. Viljanen, M., Savilahti, E., Haahtela, T., Jutuneb-Backman, K., Korpela, R., Poussa, T., et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 60 (2005), 494–500.
32. Brouwer, M.L., Wolt-Plompen, S.A., Dubois, A.E., van der Heide, S., Jansen, D.F., Hoijer, M.A., et al. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 36 (2006), 899–906.
33. Folster-Holst, R., Muller, F., Schnopp, N., Abeck, D., Kreiselmaier, I., Lenz, T., et al. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br J Dermatol 155 (2006), 1256–1261.
34. Kopp, M.V., Hennemuth, I., Heinzmann, A., Urbanek, R., Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 121 (2008), e850–e856.
35. Iemoli, E., Trabattoni, D., Parisotto, S., Borgonovo, L., Toscano, M., Rizzardini, G., et al. Probiotics reduce gut microbial translocation and improve adult atopic dermatitis. J Clin Gastroenterol 46 (2012), S33–40.
36. De Benedetto, A., Agnihothri, R., McGirt, L.Y., Bankova, L.G., Beck, L.A., Atopic dermatitis: a disease caused by innate immune defects?. J Invest Dermatol 129 (2009), 14–30.
37. Madsen, K., Cornish, A., Soper, P., McKaigney, C., Jijon, H., Yachimec, C., et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121 (2001), 580–591.
38. Won, T.J., Kim, B., Lim, Y.T., Song, D.S., Park, S.Y., Park, E.S., et al. Oral administration of Lactobacillus strains from kimchi inhibits atopic dermatitis in NC⁄Nga mice. J Appl Microbiol 110 (2011), 1195–1202.
39. Kalliomaks, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., Isolauri, E., Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 357 (2001), 1076–1079.
40. Gerasimov, S.V., Vasjuta, V.V., Myhovych, O.O., Bondarchuk, L.I., Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial. Am J Clin Dermatol 11 (2010), 351–361.